Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Citurgia BiochemicalsBOM:506373 13 PEG Ratio is 2,111.32 as of Aug. 10, 2026. GuruFocus rates BOM:506373 with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 611 Chemicals companies, Citurgia Biochemicals ranks worse than 100% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Citurgia Biochemicals's PEG Ratio or its related term are showing as below:
BOM:506373'
s PEG Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 2111.32
Current: 2111.32
During the past 13 years, Citurgia Biochemicals's highest PEG Ratio was 2111.32. The lowest was 0.00. And the median was 0.00.
BOM:506373's PEG Ratio is ranked worse than 100% of 611
companies
in the Chemicals industry
Industry Median: 2.15
vs BOM:506373: 2111.32
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Citurgia Biochemicals (BOM:506373) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Citurgia Biochemicals's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Citurgia Biochemicals PEG Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Citurgia Biochemicals's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Citurgia Biochemicals's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Citurgia Biochemicals (BOM:506373) has a PEG Ratio of 2,111.32 as of Aug. 10, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Citurgia Biochemicals and its competitors. According to the industry distribution chart, Citurgia Biochemicals ranks #611 out of 611 companies in the Chemicals industry.
Is Citurgia Biochemicals' PEG Ratio too high?
Citurgia Biochemicals' current PEG Ratio is 2,111.32. The Chemicals industry median PEG Ratio is 2.15. Citurgia Biochemicals' value of 2,111.32 is 98100.9% above this industry median. Based on the distribution chart, Citurgia Biochemicals ranks #611 out of 611 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Citurgia Biochemicals has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Citurgia Biochemicals' PEG Ratio compare to DOW?
According to the Chemicals industry distribution chart, Citurgia Biochemicals ranks #611 out of 611 companies for PEG Ratio. This places Citurgia Biochemicals in the lower half of its industry. The industry median PEG Ratio is 2.15. Citurgia Biochemicals' value of 2,111.32 is 98100.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Chemicals company?
The median PEG Ratio among Chemicals companies is 2.15, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Citurgia Biochemicals's current PEG Ratio of 2,111.32 is 98100.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Citurgia Biochemicals and its competitors. For the Chemicals industry, the median PEG Ratio is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Citurgia Biochemicals's current PEG Ratio is 2,111.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citurgia Biochemicals stock overvalued right now?
Citurgia Biochemicals (BOM:506373) has a current PEG Ratio of 2,111.32. The current PEG Ratio is 2,111.32 and 98100.9% above the Chemicals industry median of 2.15. Citurgia Biochemicals' overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Citurgia Biochemicals (BOM:506373), the current PEG Ratio is 2,111.32 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Citurgia Biochemicals Ltd is an India-based company engaged in manufacturing citric acid, calcium carbonate, and plasticizers. Citric acid is traditionally used in foods, soft drinks, confectionery, and drugs. It is also used in chemicals, where it provides stable pH conditions for polyester and nylon. Acrylic print-curing and cotton-resist printing.
13GF Score
Get the complete analysis for BOM:506373
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506373 has been successfully added to your 
